Sandoz Group AG
SIX: SDZ.SW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Swiss Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Richard Saynor
- Employees
- 22,049
- Headquarters
- Rotkreuz, Switzerland
- IPO year
- 2023
- Market cap
- CHF 28.9B
- Website
- https://www.sandoz.com
Loading SDZ…
Loading profile data…Frequently asked questions about SDZ
What does Sandoz Group AG (SDZ.SW) do?
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; a...
Where does SDZ.SW trade?
Sandoz Group AG (SDZ.SW) trades on the Swiss Exchange.
What sector is SDZ.SW in?
Sandoz Group AG (SDZ.SW) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Sandoz Group AG?
Richard Saynor is the chief executive officer of Sandoz Group AG (SDZ.SW).
Where is Sandoz Group AG headquartered?
Sandoz Group AG is headquartered in Switzerland.
Does SDZ.SW pay a dividend?
Yes — Sandoz Group AG (SDZ.SW) paid a trailing twelve-month dividend of CHF 0.80 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SDZ.SW go public?
Sandoz Group AG (SDZ.SW) completed its initial public offering in 2023.